Skip to main content
Steven Deitelzweig, MD, Internal Medicine, Jefferson, LA

StevenBDeitelzweigMDphysician

Internal Medicine • Jefferson, LA

Hospital Medicine/Hospitalist, Vascular Medicine

regional VPMA system chairman - hospital medicine

Join to view full profile

Dr. Deitelzweig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Deitelzweig's full profile

Already have an account?

  • Office

    1514 Jefferson Hwy
    Jefferson, LA 70121
    Phone+1 866-624-7637

Education & Training

  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1989 - 1992
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 1989

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 1992 - Present
  • FL State Medical License
    FL State Medical License 1994 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Abstracts/Posters

  • [Board 280] Comparison of Major Bleeding and Stroke-Related Hospital Readmissions Among Hospitalized Nonvalvular Atrial Fibrillation Patients Treated With Warfarin and...
    Steven Deitelzweig, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

  • Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Among Frail Nonvalvular Atrial Fibrillation Patients 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Press Mentions

  • Apixaban Has Edge over Other NOACs in Large, Real-World Analysis
    Apixaban Has Edge over Other NOACs in Large, Real-World AnalysisMarch 12th, 2018
  • Findings Released from Largest Real-World Data Analysis of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants
    Findings Released from Largest Real-World Data Analysis of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral AnticoagulantsMarch 11th, 2018

Professional Memberships

Dr. Steven Deitelzweig, Dr. Steven Deitelzweig, MD, Dr. S Deitelzweig, Dr. Steven B Deitelzweig